Andrea Huwiler
Bern, BE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Polypharmacy in acute and chronic kidney diseases
Journal: Innere Medizin (Heidelberg, Germany)
Published: November 14, 2023
Topical Collection: New Insights on Sphingolipids in Health and Disease.
Journal: International journal of molecular sciences
Published: May 15, 2023
Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling.
Journal: Metabolites
Published: February 23, 2023
Lipids as Targets for Renal Cell Carcinoma Therapy.
Journal: International journal of molecular sciences
Published: December 29, 2022
Loss of S1P Lyase Expression in Human Podocytes Causes a Reduction in Nephrin Expression That Involves PKCδ Activation.
Journal: International journal of molecular sciences
Published: December 29, 2022
Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols.
Journal: International journal of molecular sciences
Published: November 21, 2022
Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.
Journal: International journal of molecular sciences
Published: March 03, 2022
S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P1 and S1P3 Receptor Activation and HIF-2α Stabilization.
Journal: International journal of molecular sciences
Published: August 06, 2021
ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P1 Agonist and Functional Antagonist Potency In Vitro and In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: July 30, 2021
Last Updated: 09/26/2026